AU8934898A - Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity - Google Patents

Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity

Info

Publication number
AU8934898A
AU8934898A AU89348/98A AU8934898A AU8934898A AU 8934898 A AU8934898 A AU 8934898A AU 89348/98 A AU89348/98 A AU 89348/98A AU 8934898 A AU8934898 A AU 8934898A AU 8934898 A AU8934898 A AU 8934898A
Authority
AU
Australia
Prior art keywords
droloxifene
obesity
treatment
prostatic diseases
endometriosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU89348/98A
Other versions
AU709606B2 (en
Inventor
David D. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/276,969 external-priority patent/US5441986A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU8934898A publication Critical patent/AU8934898A/en
Application granted granted Critical
Publication of AU709606B2 publication Critical patent/AU709606B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU89348/98A 1994-07-19 1998-10-15 Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity Ceased AU709606B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/276,969 US5441986A (en) 1994-07-19 1994-07-19 Estrogen agonists as remedies for prostate and cardiovascular diseases
US276969 1994-07-19
AU24170/95A AU694220B2 (en) 1994-07-19 1995-05-26 Use of droloxifene for the treatment of prostatic diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU24170/95A Division AU694220B2 (en) 1994-07-19 1995-05-26 Use of droloxifene for the treatment of prostatic diseases

Publications (2)

Publication Number Publication Date
AU8934898A true AU8934898A (en) 1998-12-10
AU709606B2 AU709606B2 (en) 1999-09-02

Family

ID=25619259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89348/98A Ceased AU709606B2 (en) 1994-07-19 1998-10-15 Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity

Country Status (1)

Country Link
AU (1) AU709606B2 (en)

Also Published As

Publication number Publication date
AU709606B2 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
KR970704430A (en) USE OF DROLOXIFENE FOR THE TREATMENT OF PROSTATIC DISEASES ENDOMETRIOSIS AND OBESITY
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
EP2270046A3 (en) Methods and compositions for the treatment of hemolysis-associated diseases
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
EP0626174A3 (en) Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction.
ZA951831B (en) Vaccine for the prevention of respiratory and reproductive diseases of the pig
AU7772794A (en) Treatment of obesity
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
GB9618934D0 (en) Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU5563398A (en) Use of mifepristone for the treatment of psychoses and addictive behaviours
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
IL114119A0 (en) Compositions and methods for the treatment of tumors
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
EP0858340A4 (en) Combination therapy for the treatment of diabetes and obesity
IL115224A0 (en) Preparations for use in the treatment of osteoporosis
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
AU8934898A (en) Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity
EP0724842A3 (en) Preparation for the treatment of obesity
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired